{
    "2020-07-21": [
        [
            {
                "time": "",
                "original_text": "名单来了！基金二季度持仓路线曝光，这些板块仍是配置重点（附股）",
                "features": {
                    "keywords": [
                        "基金",
                        "二季度",
                        "持仓",
                        "板块",
                        "配置重点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "股票"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "揭秘送转股307只除权以来股价上涨",
                "features": {
                    "keywords": [
                        "送转股",
                        "除权",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "股票"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "海正药业公布重组预案获涨停 引入高瓴为股东",
                "features": {
                    "keywords": [
                        "海正药业",
                        "重组预案",
                        "涨停",
                        "高瓴",
                        "股东"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "44亿元收购瀚晖制药49%股权后“回归”，引入高瓴为股东，海正药业公布重组预案获涨停",
                "features": {
                    "keywords": [
                        "海正药业",
                        "重组预案",
                        "瀚晖制药",
                        "股权",
                        "高瓴",
                        "股东",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国金研究】宽基指数专题：乘宽基指数，享A股机会",
                "features": {
                    "keywords": [
                        "宽基指数",
                        "A股",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "指数基金",
                        "股票"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "公募基金二季度重仓股掀“盖头”，373只基金组团“喝”茅台",
                "features": {
                    "keywords": [
                        "公募基金",
                        "二季度",
                        "重仓股",
                        "茅台"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}